Babita Shashni

Tsukuba, 3058573, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Corrigendum to "Enzyme-responsive oleoylethanolamide-releasing nanomedicine for sustained liver delivery and therapeutic improvement in early-stage metabolic dysfunction-associated steatohepatitis (MASH)" [Journal of Controlled Release 387 (2025) 114256].

Corrigendum to "Enzyme-responsive oleoylethanolamide-releasing nanomedicine for sustained liver delivery and therapeutic improvement in early-stage metabolic dysfunction-associated steatohepatitis (MASH)" [Journal of Controlled Release 387 (2025) 114256].

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: November 02, 2025

Enzyme-responsive oleoylethanolamide-releasing nanomedicine for sustained liver delivery and therapeutic improvement in early-stage metabolic dysfunction-associated steatohepatitis (MASH).

Enzyme-responsive oleoylethanolamide-releasing nanomedicine for sustained liver delivery and therapeutic improvement in early-stage metabolic dysfunction-associated steatohepatitis (MASH).

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: June 30, 2025

Development and evaluation of a self-assembled nanoparticle-based prodrug for sustained delivery of 4-phenylbutyric acid.

Development and evaluation of a self-assembled nanoparticle-based prodrug for sustained delivery of 4-phenylbutyric acid.

Journal: Science and technology of advanced materials

Published: April 14, 2025

Butyric acid-based self-assembling nanoparticles: a potential strategy to prevent development of polycystic ovary syndrome.

Butyric acid-based self-assembling nanoparticles: a potential strategy to prevent development of polycystic ovary syndrome.

Journal: Molecular human reproduction

Published: March 24, 2025

Sorafenib-Loaded Silica-Containing Redox Nanoparticle Decreases Tumorigenic Potential of Lewis Lung Carcinoma.

Sorafenib-Loaded Silica-Containing Redox Nanoparticle Decreases Tumorigenic Potential of Lewis Lung Carcinoma.

Journal: Pharmaceutics

Published: October 30, 2024

An orally deliverable ornithine-based self-assembling polymer nanomedicine ameliorates hyperammonemia in acetaminophen-induced acute liver injury.

An orally deliverable ornithine-based self-assembling polymer nanomedicine ameliorates hyperammonemia in acetaminophen-induced acute liver injury.

Journal: Acta biomaterialia

Published: March 29, 2023

Designing poly(gamma-aminobutyric acid)-based nanoparticles for the treatment of major depressive disorders.

Designing poly(gamma-aminobutyric acid)-based nanoparticles for the treatment of major depressive disorders.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: January 06, 2023

Self-assembling polymer-based short chain fatty acid prodrugs ameliorate non-alcoholic steatohepatitis and liver fibrosis.

Self-assembling polymer-based short chain fatty acid prodrugs ameliorate non-alcoholic steatohepatitis and liver fibrosis.

Journal: Biomaterials

Published: November 30, 2022

Short-chain fatty acid-releasing nano-prodrugs for attenuating growth and metastasis of melanoma.

Short-chain fatty acid-releasing nano-prodrugs for attenuating growth and metastasis of melanoma.

Journal: Acta biomaterialia

Published: October 26, 2022

Design of a new self-assembling antioxidant nanomedicine to ameliorate oxidative stress in zebrafish embryos.

Design of a new self-assembling antioxidant nanomedicine to ameliorate oxidative stress in zebrafish embryos.

Journal: Acta biomaterialia

Published: September 25, 2022

Retraction Note to: Coffee component hydroxyl hydroquinone (HHQ) as a putative ligand for PPAR gamma and implications in breast cancer.

Retraction Note to: Coffee component hydroxyl hydroquinone (HHQ) as a putative ligand for PPAR gamma and implications in breast cancer.

Journal: BMC genomics

Published: February 15, 2022

Antioxidant Nanomedicine Significantly Enhances the Survival Benefit of Radiation Cancer Therapy by Mitigating Oxidative Stress-Induced Side Effects.

Antioxidant Nanomedicine Significantly Enhances the Survival Benefit of Radiation Cancer Therapy by Mitigating Oxidative Stress-Induced Side Effects.

Journal: Small (Weinheim an der Bergstrasse, Germany)

Published: December 31, 2020

Showing 1-12 of 24

Last Updated: 09/26/2026